LMN-101

BIOLOGICAL2 trials

Sponsors

Lumen Bioscience, Inc.

Conditions

Campylobacter InfectionsCampylobacter Jejuni Infection

Phase 1

Safety and Pharmacokinetic Study of LMN-101 in Healthy Volunteers

CompletedNCT04098263

Lumen Bioscience, Inc.Campylobacter Jejuni Infection

Start: 2019-11-15End: 2020-06-24Updated: 2025-02-04

Phase 2

LMN-101 in a Campylobacter Human Challenge Model

CompletedNCT04182490

Lumen Bioscience, Inc.Campylobacter Infections

Start: 2022-02-21End: 2022-10-04Updated: 2025-09-25